title: The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines.
abstract: The threat of future influenza pandemics and their potential for rapid spread, morbidity, and mortality has led to the development of pandemic vaccines. We generated seven reassortant pandemic live attenuated influenza vaccines (pLAIVs) with the hemagglutinin (HA) and neuraminidase (NA) genes derived from animal influenza viruses on the backbone of the six internal protein gene segments of the temperature sensitive, cold-adapted (ca) A/Ann Arbor/60 (H2N2) virus (AA/60 ca) of the licensed seasonal LAIV. The pLAIV viruses were moderately to highly restricted in replication in seronegative adults; we sought to determine the biological basis for this restriction. Avian influenza viruses generally replicate at higher temperatures than human influenza viruses and, although they shared the same backbone, the pLAIV viruses had a lower shutoff temperature than seasonal LAIV viruses, suggesting that the HA and NA influence the degree of temperature sensitivity. The pH of HA activation of highly pathogenic avian influenza viruses was greater than human and low-pathogenicity avian influenza viruses, as reported by others. However, pLAIV viruses had a consistently higher pH of HA activation and reduced HA thermostability compared to the corresponding wild-type parental viruses. From studies with single-gene reassortant viruses bearing one gene segment from the AA/60 ca virus in recombinant H5N1 or pH1N1 viruses, we found that the lower HA thermal stability and increased pH of HA activation were associated with the AA/60 M gene. Together, the impaired HA acid and thermal stability and temperature sensitivity likely contributed to the restricted replication of the pLAIV viruses we observed in seronegative adults.
  
  
  OBJECTIVE
  There is increasing evidence that the HA stability of influenza viruses depends on the virus strain and host species and that HA stability can influence replication, virulence, and transmission of influenza A viruses in different species. We investigated the HA stability of pandemic live attenuated influenza vaccine (pLAIV) viruses and observed that the pLAIV viruses consistently had a less stable HA than the corresponding wild-type influenza viruses. The reduced HA stability and temperature sensitivity of the pLAIV viruses may account for their restricted replication in clinical trials.
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: O'Donnell
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Leatrice
authors.initials: L
authors.lastname: Vogel
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Matsuoka
authors.affiliation: MedImmune LLC, Mountain View, California, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Jin
authors.affiliation: Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, Maryland, USA ksubbarao@niaid.nih.gov.
authors.forename: Kanta
authors.initials: K
authors.lastname: Subbarao
mesh_terms: D004355:Drug Stability; D006388:Hemagglutinins / Q000737:chemistry*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D053118:Influenza A Virus, H1N1 Subtype / Q000737:chemistry* / Q000235:genetics / Q000502:physiology*; D007252:Influenza Vaccines / Q000737:chemistry* / Q000235:genetics; D055550:Protein Stability / Q000187:drug effects / Q000528:radiation effects; D016865:Reassortant Viruses / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D013696:Temperature; D014613:Vaccines, Attenuated / Q000737:chemistry / Q000235:genetics; D014763:Viral Matrix Proteins / Q000235:genetics*; D014779:Virus Replication / Q000187:drug effects / Q000528:radiation effects
chemical_list: D006388:Hemagglutinins; D007252:Influenza Vaccines; C488936:M1 protein, Influenza A virus; D014613:Vaccines, Attenuated; D014763:Viral Matrix Proteins